Lappoxo

Omeprazole, the active ingredient in Lappoxo, is a proton pump inhibitor presented as a 20 mg tablet for oral use. It reduces stomach acid production and is used to treat gastro‑reflux related conditions in adults. GNH USA supplies Lappoxo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Omeprazole acts on the gastric acid‑secretion pathway and is indicated for several acid‑related disorders. - Gastro‑esophageal reflux disease (GERD): provides relief of heartburn and promotes healing of erosive esophagitis. - Peptic ulcer disease (PUD): supports ulcer healing and reduces recurrence. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion. - Helicobacter pylori eradication regimens: used as adjunct‑therapy in combination regimens. - NSAID‑associated ulcer prophylaxis: lowers risk of ulcer development in chronic NSAID users.

Adverse reactions to omeprazole are generally mild to moderate and vary by individual.

Common Side Effects: - Headache: mild, transient headache. - Diarrhea: loose stools, often self‑limiting. - Nausea: occasional feeling of queasiness. - Abdominal pain: mild discomfort in the stomach area. - Flatulence: increased gas formation. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis risk. - Acute interstitial nephritis: kidney inflammation. - Hypomagnesemia: low magnesium levels with prolonged use. - Stevens‑Johnson syndrome: rare severe skin reaction. - Liver enzyme elevation: increased ALT/AST. - Fracture risk: potential decrease in bone density with long‑term therapy.

When using Lappoxo, consider the following safety measures: - Assess renal function: adjust use in patients with severe kidney impairment. - Monitor magnesium levels: check periodically during long‑term therapy. - Evaluate bone health: consider calcium/vitamin D supplementation for prolonged use. - Review drug history: avoid concurrent use with drugs that require acidic pH for absorption. - Pregnancy and lactation: use only if clearly needed after risk‑benefit assessment. - Store at ambient temperature: keep below 25°C, retain original packaging, protect from moisture.

Omeprazole may interact with several medicines, requiring attention to dosage and monitoring.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect. - Atazanavir: decreased antiviral absorption. - Dasatinib: lowered plasma concentrations.

Moderate Interactions (Monitor Closely): - Warfarin: potential INR fluctuation. - Phenytoin: altered serum levels. - Methotrexate: increased toxicity risk. - Digoxin: enhanced absorption. - Ketoconazole: reduced antifungal efficacy.